Oncologist Mikhail Blagosklonny Advocates Cancer Drug to Increase Longevity

Mikhail Blagosklonny teaches at the Roswell Park Cancer Institute in Buffalo, NY as a professor in the oncology department. His areas of study are cancer and aging. He graduated with an M.D. in internal medicine and a Ph. D. in cardiology and experimental medicine from the First Pavlov State Medical University of St. Peterburg, Russia. In 2002, Dr. Blagosklonny became the associate professor of medicine at the New York Medical College in Valhalla, NY. Later, he accepted a position at the Ordway Research Institute in Albany, NY as a senior scientist and remained in this position until 2009 when he moved on to work for the Roswell Park Cancer Institute.

View: https://scholar.google.com/citations?user=REO9YogAAAAJ&hl=en

At the Roswell Park Cancer Institute, Dr. Blagosklonny studies cancer, cancer therapies, aging, biogerontology (the study of the underlying mechanisms causing aging) and anti-aging drugs. He researches cancer therapies intended to target only cancer cells, protecting the healthy cells from damage. Dr. Blagosklonny developed a hypothesis concerning TOR Signaling playing a role in cancer and aging. He recommended using Rapamycin, a popular cancer drug, as a life extension treatment in older patients. He is one of the most zealous advocates of using Rapamycin for longevity.

Dr. Blagosklonny is the editor-in-chief for the publications “Oncotarget”, “Cell Cycle” and “Aging”. He is also an editor of “Cancer Biology & Therapy” and “Cell Death & Differentiation.”

Mikhail Blagosklonny believes that cancer can be cured and that aging can be controlled. Mikhail has dedicated his life to oncology research, driven by his love for humanity and hope for a disease-free world. Visit ResearchGate.Net to learn more about Mikhail’s latest work.

David Giertz on Social Security Tools and Retirement Plans

The President of Nationwide Financial, David Giertz recently went on an interview on the Wall Street Journals’ program, Wealth Adviser. The one-minute long video snippet begins with the host, Veronica Dagher.

Social Security and Advisors

The hostess, Veronica, wasted no time and dug straight to work. Her first question to Mr. Grietz was for him to help the viewer understand why advisers weren’t merely doing enough to help them, the consumers, secure their social security. In response, David quoted the findings of a recent survey conducted by Nationwide Financials Inc.

In a nutshell, the study showed that many people would eventually end up with no social security in their retirement owing to the incompetence of their advisors on Twitter. Also, 4 out of 5 people were going to change their adviser if they weren’t talking to them about the retirement and social security measures in place.

Turning Social Security Tools On

It’s very important, according, to David for you to turn on the social security tools at the right time at https://about.me/davidgiertz. Turn them too early and you stand to loose up to 300K in a period of 25 years. That’s 12 K a year or a thousand dollars per month.

2700 Rules

Advisors aren’t enlightening their customers on social security. According to David Giertz, many advisors are grossly incompetent, and only a handful of them have an understanding of the social security handbook which contains a whopping 2700 rules.

About David Giertz

David Giertz’s company in Columbus, Ohio deals in selling retirement packages to private sector workers. Additionally, his firm offers annuities, mutual funds, and life insurance covers to interested persons. He attained an MBA from the University Of Miami School Of Business in 2003.

David G. studied at Millikin University in the years 0f 1982 to 1986. Today, he’s very active on social media, and he’s a regular guest on many of the leading business shows. Check out his Linkedin page and read all the articles he has ever published on retirement and on selecting advisors on angel.co.